ResearcherThe First People's Hospital of NeijiangNo recent work listed

Xiao Chen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression. Co-author DOI 10.18632/aging.103487 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jie Wang · 1 shared paper, 2020 · strength 0.12
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487 ↗
Qin Yang · 1 shared paper, 2020 · strength 0.12
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487 ↗
Fei Xie · 1 shared paper, 2020 · strength 0.12
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487 ↗
Hao Hua · 1 shared paper, 2020 · strength 0.12
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487 ↗
Tinggang Mou · 1 shared paper, 2020 · strength 0.12
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.